miun.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Moist smokeless tobacco (Snus) use and risk of Parkinson's disease
Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm.
Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm; Univ Southern Calif, Dept Psychol, Los Angeles, CA USA.
Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm.
Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm.
Show others and affiliations
2017 (English)In: International Journal of Epidemiology, ISSN 0300-5771, E-ISSN 1464-3685, Vol. 46, no 3, p. 872-880, article id dyw294Article in journal (Refereed) Published
Abstract [en]

Background: Cigarette smoking is associated with a lower risk of Parkinson's disease. It is unclear what constituent of tobacco smoke may lower the risk. Use of Swedish moist smokeless tobacco (snus) can serve as a model to disentangle what constituent of tobacco smoke may lower the risk. The aim of this study was to determine whether snus use was associated with a lower risk of Parkinson's disease. Methods: Individual participant data were collected from seven prospective cohort studies, including 348 601 men. We used survival analysis with multivariable Cox regression to estimate study-specific relative risk of Parkinson's disease due to snus use, and random-effects models to pool estimates in a meta-analysis. The primary analyses were restricted to never-smokers to eliminate the potential confounding effect of tobacco smoking. Results: During a mean follow-up time of 16.1 years, 1199 incident Parkinson's disease cases were identified. Among men who never smoked, ever-snus users had about 60% lower Parkinson's disease risk compared with never-snus users [pooled hazard ratio (HR) 0.41, 95% confidence interval (CI) 0.28-0.61]. The inverse association between snus use and Parkinson's disease risk was more pronounced in current (pooled HR 0.38, 95% CI 0.23-0.63), moderate-heavy amount (pooled HR 0.41, 95% CI 0.19-0.90) and long-term snus users (pooled HR 0.44, 95% CI 0.24-0.83). Conclusions: Non-smoking men who used snus had a substantially lower risk of Parkinson's disease. Results also indicated an inverse dose-response relationship between snus use and Parkinson's disease risk. Our findings suggest that nicotine or other components of tobacco leaves may influence the development of Parkinson's disease.

Place, publisher, year, edition, pages
2017. Vol. 46, no 3, p. 872-880, article id dyw294
Keywords [en]
Parkinson's disease, individual participant data, risk factors, epidemiology, nicotine
National Category
Health Sciences
Identifiers
URN: urn:nbn:se:miun:diva-31833DOI: 10.1093/ije/dyw294ISI: 000406242600021Scopus ID: 2-s2.0-85027731926OAI: oai:DiVA.org:miun-31833DiVA, id: diva2:1148899
Available from: 2017-10-12 Created: 2017-10-12 Last updated: 2017-11-29Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records BETA

Knutsson, Anders

Search in DiVA

By author/editor
Knutsson, Anders
By organisation
Department of Health Sciences
In the same journal
International Journal of Epidemiology
Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 10 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf